JNJ
Price
$176.66
Change
+$1.21 (+0.69%)
Updated
Aug 29, 02:10 PM (EDT)
Capitalization
422.54B
53 days until earnings call
SNYNF
Price
$99.39
Change
-$0.87 (-0.87%)
Updated
Aug 25 closing price
Capitalization
122.77B
Interact to see
Advertisement

JNJ vs SNYNF

Header iconJNJ vs SNYNF Comparison
Open Charts JNJ vs SNYNFBanner chart's image
Johnson & Johnson
Price$176.66
Change+$1.21 (+0.69%)
Volume$15K
Capitalization422.54B
Sanofi
Price$99.39
Change-$0.87 (-0.87%)
Volume$413
Capitalization122.77B
JNJ vs SNYNF Comparison Chart in %
Loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JNJ vs. SNYNF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNJ is a Buy and SNYNF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (JNJ: $175.45 vs. SNYNF: $99.39)
Brand notoriety: JNJ: Notable vs. SNYNF: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JNJ: 74% vs. SNYNF: 0%
Market capitalization -- JNJ: $422.54B vs. SNYNF: $122.77B
JNJ [@Pharmaceuticals: Major] is valued at $422.54B. SNYNF’s [@Pharmaceuticals: Major] market capitalization is $122.77B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $656.17B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JNJ’s FA Score shows that 3 FA rating(s) are green whileSNYNF’s FA Score has 1 green FA rating(s).

  • JNJ’s FA Score: 3 green, 2 red.
  • SNYNF’s FA Score: 1 green, 4 red.
According to our system of comparison, JNJ is a better buy in the long-term than SNYNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JNJ’s TA Score shows that 2 TA indicator(s) are bullish while SNYNF’s TA Score has 7 bullish TA indicator(s).

  • JNJ’s TA Score: 2 bullish, 4 bearish.
  • SNYNF’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, SNYNF is a better buy in the short-term than JNJ.

Price Growth

JNJ (@Pharmaceuticals: Major) experienced а -1.23% price change this week, while SNYNF (@Pharmaceuticals: Major) price change was -0.64% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.91%. For the same industry, the average monthly price growth was +1.24%, and the average quarterly price growth was +11.83%.

Reported Earning Dates

JNJ is expected to report earnings on Oct 21, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.91% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($423B) has a higher market cap than SNYNF($123B). JNJ has higher P/E ratio than SNYNF: JNJ (18.78) vs SNYNF (16.58). JNJ YTD gains are higher at: 24.243 vs. SNYNF (4.511). JNJ has higher annual earnings (EBITDA): 35.6B vs. SNYNF (12.6B). SNYNF has more cash in the bank: 15.4B vs. JNJ (3.25B). SNYNF has less debt than JNJ: SNYNF (22.3B) vs JNJ (50.8B). JNJ has higher revenues than SNYNF: JNJ (90.6B) vs SNYNF (45.7B).
JNJSNYNFJNJ / SNYNF
Capitalization423B123B344%
EBITDA35.6B12.6B283%
Gain YTD24.2434.511537%
P/E Ratio18.7816.58113%
Revenue90.6B45.7B198%
Total Cash3.25B15.4B21%
Total Debt50.8B22.3B228%
FUNDAMENTALS RATINGS
JNJ vs SNYNF: Fundamental Ratings
JNJ
SNYNF
OUTLOOK RATING
1..100
1823
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
5
Undervalued
PROFIT vs RISK RATING
1..100
29100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
2375
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7528

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNYNF's Valuation (5) in the null industry is in the same range as JNJ (16) in the Pharmaceuticals Major industry. This means that SNYNF’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Profit vs Risk Rating (29) in the Pharmaceuticals Major industry is significantly better than the same rating for SNYNF (100) in the null industry. This means that JNJ’s stock grew significantly faster than SNYNF’s over the last 12 months.

JNJ's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as SNYNF (100) in the null industry. This means that JNJ’s stock grew similarly to SNYNF’s over the last 12 months.

JNJ's Price Growth Rating (23) in the Pharmaceuticals Major industry is somewhat better than the same rating for SNYNF (75) in the null industry. This means that JNJ’s stock grew somewhat faster than SNYNF’s over the last 12 months.

JNJ's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as SNYNF (100) in the null industry. This means that JNJ’s stock grew similarly to SNYNF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JNJSNYNF
RSI
ODDS (%)
Bearish Trend 2 days ago
36%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
54%
Bullish Trend 2 days ago
61%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
59%
MACD
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
42%
Bullish Trend 2 days ago
49%
Advances
ODDS (%)
Bullish Trend 8 days ago
41%
Bullish Trend 12 days ago
49%
Declines
ODDS (%)
Bearish Trend 4 days ago
43%
Bearish Trend 19 days ago
51%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
55%
Aroon
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MEM33.720.36
+1.09%
Matthews Emerging Markets Eq Actv ETF
AVES55.900.32
+0.57%
Avantis Emerging Markets Value ETF
IUSG158.830.82
+0.52%
iShares Core S&P US Growth ETF
DUKQ27.020.06
+0.24%
Ocean Park Domestic ETF
MFUS54.96-0.03
-0.05%
PIMCO RAFI Dyn Multi-Factor US Eq ETF

SNYNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNYNF has been loosely correlated with SNY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SNYNF jumps, then SNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYNF
1D Price
Change %
SNYNF100%
N/A
SNY - SNYNF
37%
Loosely correlated
-0.34%
NVSEF - SNYNF
24%
Poorly correlated
N/A
AZN - SNYNF
23%
Poorly correlated
+0.08%
JNJ - SNYNF
22%
Poorly correlated
-0.76%
NVS - SNYNF
21%
Poorly correlated
-0.33%
More